The bone anabolic carotenoid p-hydroxycinnamic acid promotes osteoblast mineralization and suppresses osteoclast differentiation by antagonizing NF-κB activation.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  International Journal of Molecular Medicine

• Publication date

  2012-09-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.3892/ijmm.2012.1043PMID 22751682
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Quercetin, a potent suppressor of NF-κB and Smad activation in osteoblasts.

  2011cited by this paper
• Honokiol stimulates osteoblastogenesis by suppressing NF-κB activation.

  2011cited by this paper
• Zinc stimulates osteoblastogenesis and suppresses osteoclastogenesis by antagonizing NF-κB activation

  2011cited by this paper
• Direct bone formation during distraction osteogenesis does not require TNFalpha receptors and elevated serum TNFalpha fails to inhibit bone formation in TNFR1 deficient mice.

  2010cited by this paper
• Vitamin K2 stimulates osteoblastogenesis and suppresses osteoclastogenesis by suppressing NF-κB activation.

  2010cited by this paper
• Inhibition of Osteoblast Functions by IKK/NF-κB in Osteoporosis

  2009cited by this paper
• The bone anabolic carotenoid β-cryptoxanthin enhances transforming growth factor-β1-induced SMAD activation in MC3T3 preosteoblasts

  2009cited by this paper
• Tumor Necrosis Factor α Represses Bone Morphogenetic Protein (BMP) Signaling by Interfering with the DNA Binding of Smads through the Activation of NF-κB*

  2009cited by this paper
• The bone anabolic carotenoids p-hydroxycinnamic acid and β-cryptoxanthin antagonize NF-κB activation in MC3T3 preosteoblasts.

  2009cited by this paper
• Restoration of Regenerative Osteoblastogenesis in Aged Mice: Modulation of TNF

  2009cited by this paper
• The bone anabolic carotenoid beta-cryptoxanthin enhances transforming growth factor-beta1-induced SMAD activation in MC3T3 preosteoblasts.

  2009cited by this paper
• Ubiquitin Ligase Smurf1 Mediates Tumor Necrosis Factor-induced Systemic Bone Loss by Promoting Proteasomal Degradation of Bone Morphogenetic Signaling Proteins*

  2008cited by this paper
• Update on the role of vitamin K in skeletal health.

  2008cited by this paper
• Oral administration of phytocomponent p-hydroxycinnamic acid prevents bone loss in ovariectomized rats

  2008cited by this paper
• Suppression of NF-kappaB activation blocks osteoclastic bone resorption during estrogen deficiency.

  2008cited by this paper
• RelA/p65 promotes osteoclast differentiation by blocking a RANKL-induced apoptotic JNK pathway in mice.

  2008cited by this paper
• SDX-308, a nonsteroidal anti-inflammatory agent, inhibits NF-kappaB activity, resulting in strong inhibition of osteoclast formation/activity and multiple myeloma cell growth.

  2007cited by this paper
• Endogenous TNFα Lowers Maximum Peak Bone Mass and Inhibits Osteoblastic Smad Activation Through NF‐κB

  2007cited by this paper
• Oral administration of phytocomponent p-hydroxycinnamic acid has a preventive effect on bone loss in streptozotocin-induced diabetic rats.

  2007cited by this paper
• Phytocomponent p-hydroxycinnamic acid inhibits osteoclast-like cell formation in mouse bone marrow cultures.

  2007cited by this paper
• Smad7 mediates inhibition of Saos2 osteosarcoma cell differentiation by NFkappaB.

  2006cited by this paper
• Estrogen deficiency and bone loss: an inflammatory tale.

  2006cited by this paper
• Smad7 mediates inhibition of Saos2 osteosarcoma cell differentiation by NFκB

  2006cited by this paper
• Phytocomponent p-hydroxycinnamic acid stimulates bone formation and inhibits bone resorption in rat femoral tissues in vitro

  2006cited by this paper
• The IkappaB kinase (IKK) inhibitor, NEMO-binding domain peptide, blocks osteoclastogenesis and bone erosion in inflammatory arthritis.

  2004cited by this paper
• Image processing with ImageJ

  2004cited by this paper
• Tumor necrosis factor-alpha: molecular and cellular mechanisms in skeletal pathology.

  2003cited by this paper
• TNFalpha potently activates osteoclasts, through a direct action independent of and strongly synergistic with RANKL.

  2002cited by this paper
• TNFα Potently Activates Osteoclasts, through a Direct Action Independent of and Strongly Synergistic with RANKL.

  2002cited by this paper
• Tumor Necrosis Factor-α (TNF) Stimulates RANKL-induced Osteoclastogenesis via Coupling of TNF Type 1 Receptor and RANK Signaling Pathways*

  2001cited by this paper
• TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand.

  2000cited by this paper
• Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha.

  2000cited by this paper
• Anabolic effect of genistein in osteoblastic MC3T3-E1 cells.

  2000cited by this paper
• Required and nonessential functions of nuclear factor-kappa B in bone cells.

  1999cited by this paper

• Polyphenols and Functionalized Hydrogels for Osteoporotic Bone Regeneration

  2024cites this paper
• Discovery of potential biomarkers for osteoporosis using LC/GC−MS metabolomic methods

  2024cites this paper
• Role of vitamins beyond vitamin D3 in bone health and osteoporosis (Review)

  2023cites this paper
• Metabolic Regularity of Bioactive Compounds in Epimedium in Rats Based on LC-MS Analysis Technology

  2023cites this paper
• Lophatherum gracile Bronghiart Suppresses Receptor Activator of Nuclear Factor Kappa-B Ligand-Stimulated Osteoclastogenesis and Prevents Ovariectomy-Induced Osteoporosis

  2022cites this paper
• trans-Cinnamic acid, but not p-coumaric acid or methyl cinnamate, induces fibroblast migration through PKA- and p38-MAPK signalling pathways.

  2021cites this paper
• Hemp Seeds in Post-Arthroplasty Rehabilitation: A Pilot Clinical Study and an In Vitro Investigation

  2021cites this paper
• Tanshinone IIA attenuates polyethylene-induced osteolysis in a mouse model: The key role of miR-155-5p/FOXO3 axis

  2021cites this paper
• Functionalization with a Polyphenol-Rich Pomace Extract Empowers a Ceramic Bone Filler with In Vitro Antioxidant, Anti-Inflammatory, and Pro-Osteogenic Properties

  2021cites this paper
• The phytochemical p-hydroxycinnamic acid suppresses the growth and stimulates the death in human liver cancer HepG2 cells

  2021cites this paper
• The botanical component p-hydroxycinnamic acid suppresses the growth and bone metastatic activity of human prostate cancer PC-3 cells in vitro

  2020cites this paper
• AP-002: A novel inhibitor of osteoclast differentiation and function without disruption of osteogenesis.

  2020cites this paper
• Biomaterial-induced microenvironment and host reaction in bone regeneration

  2020cites this paper
• Oral supplementation with p-coumaric acid protects mice against diabetes-associated spontaneous destruction of periodontal tissue.

  2019cites this paper
• The combination of catechin, baicalin and β-caryophyllene potentially suppresses the production of inflammatory cytokines in mouse macrophages in vitro.

  2019cites this paper
• Tanshinone IIA exerts beneficial effects on fracture healing in vitro and in vivo.

  2019cites this paper
• Effect of Lactoferrin on the Expression Profiles of Long Non-coding RNA during Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells

  2019cites this paper
• miRNA-125b Regulates Osteogenic Differentiation of Periodontal Ligament Cells Through NKIRAS2/NF-κB Pathway

  2018cites this paper
• Mesenchymal stem cells in multiple myeloma: a therapeutical tool or target?

  2018cites this paper
• Molecular signaling mechanisms behind polyphenol-induced bone anabolism

  2017cites this paper
• The botanical molecule p-hydroxycinnamic acid as a new osteogenic agent: insight into the treatment of cancer bone metastases

  2016cites this paper
• The combination of β-caryophyllene, baicalin and catechin synergistically suppresses the proliferation and promotes the death of RAW267.4 macrophages in vitro.

  2016cites this paper
• The osteogenic factor p-hydroxycinnamic acid as an active component in wasabi leafstalk: role in osteoporosis prevention

  2015cites this paper
• Coffee and Bone Metabolism

  2015cites this paper
• Regulatory Tweak/Fn14 signaling pathway as a potent target for controlling bone loss.

  2015cites this paper
• The flavonoid p-hydroxycinnamic acid exhibits anticancer effects in human pancreatic cancer MIA PaCa-2 cells in vitro: Comparison with gemcitabine.

  2015cites this paper
• Novel osteogenic factors prevents osteoporosis in obese type 2 diabetes

  2015cites this paper
• The flavonoid p-hydroxycinnamic acid mediates anticancer effects on MDA-MB-231 human breast cancer cells in vitro: Implications for suppression of bone metastases.

  2015influential citation
• Protective Effects of Dietary Carotenoids on Risk of Hip Fracture in Men: The Singapore Chinese Health Study

  2014cites this paper
• Indirubin‐3′‐Oxime Reverses Bone Loss in Ovariectomized and Hindlimb‐Unloaded Mice Via Activation of the Wnt/β‐Catenin Signaling

  2014cites this paper
• The Role of Inflammatory Cytokines, the RANKL/OPG Axis, and the Immunoskeletal Interface in Physiological Bone Turnover and Osteoporosis

  2013cites this paper
• Bioactive flavonoid p-hydroxycinnamic acid stimulates osteoblastogenesis and suppresses adipogenesis in bone marrow culture

  2013cites this paper
• Dietary component p-coumaric acid suppresses monosodium urate crystal-induced inflammation in rats

  2013cites this paper
• The osteogenic effect of bioactive flavonoid p-hydroxycinnamic acid: development in osteoporosis treatment

  2013cites this paper